Manzanedo, I <br/><br/>
The use of cisplatin plus doxorubicin or paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) for stage IIIC or IV epithelial ovarian cancer: a comparative study.  [electronic resource] 

 -  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico  Oct 2019 
 - 1357-1363 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1699-3055 
<br/><br/><label>Standard No.: </label>10.1007/s12094-019-02065-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Ovarian Epithelial--mortality<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy--adverse effects<br/>Cytoreduction Surgical Procedures--adverse effects<br/>Doxorubicin--administration & dosage<br/>Female<br/>Humans<br/>Hyperthermia, Induced--adverse effects<br/>Middle Aged<br/>Neoplasm, Residual<br/>Ovarian Neoplasms--mortality<br/>Paclitaxel--administration & dosage<br/>Peritoneal Neoplasms--mortality<br/>Prospective Studies<br/>Retrospective Studies